Xeris Biopharma Holdings Inc (XERS)
Capital Lease Obligations
$36.85M
Quarterly · Period ending: · USD
XERS Capital Lease Obligations
Latest reported$36.85Mperiod ending
Latest reported$36.85Mperiod ending
XERS Quarterly Capital Lease Obligations ($0.00 → $36.85M)
Quarterly capital lease obligations
High-resolution chart · PNG
XERS capital lease obligations history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Capital Lease Obligations (USD) |
|---|---|
| 36,852,000 | |
| 0 | |
| 0 | |
| 0 | |
| 38,597,000 | |
| 38,987,000 | |
| 39,339,000 | |
| 39,681,000 | |
| 39,323,000 | |
| 39,021,000 | |
| 38,259,000 | |
| 37,520,000 | |
| 36,806,000 | |
| 10,794,000 | |
| 10,982,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |